Posted in | News | Materials Analysis

EVIDENT, 89 North and CrestOptics Collaborate to Advance Live-Cell Imaging

Evident, a premier manufacturer of life science imaging systems, 89 North, a leader in illumination and imaging technology, and CrestOptics, a leader in advanced microscopy systems, announced a collaborative agreement to promote confocal spinning-disk technology to advance live-cell imaging in the Americas.

Glomerulus z-stack at 60x. Captured on the Crest CICERO system. Image Ctredit: CrestOptics.

The technology combines the microscopes and optics from Evident with the spinning-disk confocal platforms from CrestOptics and laser diode illuminators from 89 North. Integrating these leading solutions expands the range of live-cell imaging tools available to researchers and enables customized designs to fit specific needs.

CrestOptics’ solutions feature strong optical design and flexibility, so they can be adapted into tailor-made systems to meet demanding imaging requirements. These solutions range from the Cicero, a user-friendly system that introduces researchers to confocal spinning-disk technology, to the X-Light V3, a cutting-edge confocal system designed to meet challenging imaging needs. This range of options complements the high-end IXplore SpinSR super-resolution spinning-disk confocal system from Evident.

These spinning-disk units are powered by laser diode illuminators (LDIs) from 89 North. Designed with 89 North’s optical expertise, these fully integrated laser light sources offer enhanced power, stability and flexibility. With an LDI, researchers can access a broad range of fluorescence markers, including the near-infrared (NIR) spectrum, making it a leading choice for live-cell applications.

Evident’s range of inverted and upright microscope frames and world-class optics enable researchers to take full advantage of the systems from CrestOptics and 89 North. These solutions can be tuned to specific research needs, from upgrading a widefield microscope to creating a multimodal system for a wide range of applications.

“We are delighted to collaborate with 89 North and CrestOptics to expand our spinning-disk confocal solutions,” said Lee Wagstaff, the Vice President of Life Science Sales and Marketing at Evident Americas. “These systems complement our portfolio of optics and microscopes, empowering labs and core facilities with a range of tools to expand their live-cell imaging capabilities.”

“Together, we offer comprehensive sales and support for live-cell imaging solutions across the broadest possible range of applications,” said Sean Lin, Director of Sales and Marketing at 89 North. “We are extremely pleased with the strong support and seamless integration that this collaboration will create.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Evident Corporation - NDT. (2023, November 29). EVIDENT, 89 North and CrestOptics Collaborate to Advance Live-Cell Imaging. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=62235.

  • MLA

    Evident Corporation - NDT. "EVIDENT, 89 North and CrestOptics Collaborate to Advance Live-Cell Imaging". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=62235>.

  • Chicago

    Evident Corporation - NDT. "EVIDENT, 89 North and CrestOptics Collaborate to Advance Live-Cell Imaging". AZoM. https://www.azom.com/news.aspx?newsID=62235. (accessed November 21, 2024).

  • Harvard

    Evident Corporation - NDT. 2023. EVIDENT, 89 North and CrestOptics Collaborate to Advance Live-Cell Imaging. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=62235.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.